{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:43:21Z","timestamp":1792673001493,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019004","name":"Deanship of Research, Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20210234"],"award-info":[{"award-number":["20210234"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019004","name":"Deanship of Research, Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20210234"],"award-info":[{"award-number":["20210234"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11110-2","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T23:42:19Z","timestamp":1747784539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cytomegalovirus and Epstein-Barr virus infections among Jordanians: seroprevalence and associated factors"],"prefix":"10.1186","volume":"25","author":[{"given":"Hassan M.","family":"Kofahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer F.","family":"Swedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maen","family":"Aljezawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"11110_CR1","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.crmicr.2024.100257","volume":"7","author":"SM Lawrence","year":"2024","unstructured":"Lawrence SM. Human cytomegalovirus and neonatal infection. Curr Res Microb Sci. 2024;7:100257. https:\/\/doi.org\/10.1016\/j.crmicr.2024.100257.","journal-title":"Curr Res Microb Sci"},{"key":"11110_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-540-77349-8_4","volume":"325","author":"C Sinzger","year":"2008","unstructured":"Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol. 2008;325:63\u201383. https:\/\/doi.org\/10.1007\/978-3-540-77349-8_4.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"11110_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3947\/ic.2024.0016","volume":"56","author":"K Huh","year":"2024","unstructured":"Huh K, et al. Prevention of cytomegalovirus infection in solid organ transplant recipients: guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation. Infect Chemother. 2024;56(1):101\u201321. https:\/\/doi.org\/10.3947\/ic.2024.0016.","journal-title":"Infect Chemother"},{"key":"11110_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-3-540-77349-8_17","volume":"325","author":"M Reeves","year":"2008","unstructured":"Reeves M, Sinclair J. Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol. 2008;325:297\u2013313. https:\/\/doi.org\/10.1007\/978-3-540-77349-8_17.","journal-title":"Curr Top Microbiol Immunol"},{"key":"11110_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1743-422X-5-47","volume":"5","author":"PI Rafailidis","year":"2008","unstructured":"Rafailidis PI, et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47. https:\/\/doi.org\/10.1186\/1743-422X-5-47.","journal-title":"Virol J"},{"issue":"1","key":"11110_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/v13010020","volume":"13","author":"A Njue","year":"2020","unstructured":"Njue A, et al. The role of congenital cytomegalovirus infection in adverse birth outcomes: a review of the potential mechanisms. Viruses. 2020;13(1):20. https:\/\/doi.org\/10.3390\/v13010020.","journal-title":"Viruses"},{"issue":"1","key":"11110_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.virusres.2006.01.002","volume":"117","author":"DJ McGeoch","year":"2006","unstructured":"McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Virus Res. 2006;117(1):90\u2013104. https:\/\/doi.org\/10.1016\/j.virusres.2006.01.002.","journal-title":"Virus Res"},{"issue":"7","key":"11110_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481\u201392. https:\/\/doi.org\/10.1056\/NEJM200008173430707.","journal-title":"N Engl J Med"},{"issue":"1","key":"11110_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ijc.2910350107","volume":"35","author":"QY Yao","year":"1985","unstructured":"Yao QY, Rickinson AB, Epstein MA. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer. 1985;35(1):35\u201342. https:\/\/doi.org\/10.1002\/ijc.2910350107.","journal-title":"Int J Cancer"},{"key":"11110_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coviro.2015.08.002","volume":"15","author":"AD Hislop","year":"2015","unstructured":"Hislop AD. Early virological and immunological events in Epstein-Barr virus infection. Curr Opin Virol. 2015;15:75\u20139. https:\/\/doi.org\/10.1016\/j.coviro.2015.08.002.","journal-title":"Curr Opin Virol"},{"issue":"3","key":"11110_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s1074-7613(00)80622-6","volume":"9","author":"GJ Babcock","year":"1998","unstructured":"Babcock GJ, et al. EBV persistence in memory B cells in vivo. Immunity. 1998;9(3):395\u2013404. https:\/\/doi.org\/10.1016\/s1074-7613(00)80622-6.","journal-title":"Immunity"},{"issue":"107","key":"11110_CR12","doi-asserted-by":"publisher","first-page":"10fs77","DOI":"10.1126\/scitranslmed.3002878","volume":"3","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, et al. Epstein-Barr virus an important vaccine target for cancer prevention. Sci Transl Med. 2011;3(107):10fs77. https:\/\/doi.org\/10.1126\/scitranslmed.3002878.","journal-title":"Sci Transl Med"},{"issue":"4","key":"11110_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, et al. A review of human carcinogens\u2013Part B: biological agents. Lancet Oncol. 2009;10(4):321\u20132. https:\/\/doi.org\/10.1016\/s1470-2045(09)70096-8.","journal-title":"Lancet Oncol"},{"issue":"15","key":"11110_CR14","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.3390\/ijms25158160","volume":"25","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. Epstein-Barr viruses: their immune evasion strategies and implications for autoimmune diseases. Int J Mol Sci. 2024;25(15):8160. https:\/\/doi.org\/10.3390\/ijms25158160.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"11110_CR15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1086\/652438","volume":"50","author":"SL Bate","year":"2010","unstructured":"Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988\u20132004. Clin Infect Dis. 2010;50(11):1439\u201347. https:\/\/doi.org\/10.1086\/652438.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"11110_CR16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1017\/S0950268817000103","volume":"145","author":"D Antona","year":"2017","unstructured":"Antona D, et al. Seroprevalence of cytomegalovirus infection in France in 2010. Epidemiol Infect. 2017;145(7):1471\u20138. https:\/\/doi.org\/10.1017\/S0950268817000103.","journal-title":"Epidemiol Infect"},{"key":"11110_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2014.11.033","volume":"63","author":"MJ Korndewal","year":"2015","unstructured":"Korndewal MJ, et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53\u20138. https:\/\/doi.org\/10.1016\/j.jcv.2014.11.033.","journal-title":"J Clin Virol"},{"issue":"3\u20134","key":"11110_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00508-016-1069-7","volume":"129","author":"T Vilibic-Cavlek","year":"2017","unstructured":"Vilibic-Cavlek T, et al. Seroepidemiology of cytomegalovirus infections in Croatia. Wien Klin Wochenschr. 2017;129(3\u20134):129\u201335. https:\/\/doi.org\/10.1007\/s00508-016-1069-7.","journal-title":"Wien Klin Wochenschr"},{"issue":"7","key":"11110_CR19","doi-asserted-by":"publisher","first-page":"e0200267","DOI":"10.1371\/journal.pone.0200267","volume":"13","author":"R Lachmann","year":"2018","unstructured":"Lachmann R, et al. Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS ONE. 2018;13(7):e0200267. https:\/\/doi.org\/10.1371\/journal.pone.0200267.","journal-title":"PLoS ONE"},{"issue":"3","key":"11110_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S2055-6640(20)30456-8","volume":"2","author":"M Bates","year":"2016","unstructured":"Bates M, Brantsaeter AB. Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen. J Virus Erad. 2016;2(3):136\u201342.","journal-title":"J Virus Erad"},{"issue":"7","key":"11110_CR21","first-page":"627","volume":"18","author":"M Shaiegan","year":"2015","unstructured":"Shaiegan M, et al. Meta-analysis of cytomegalovirus seroprevalence in volunteer blood donors and healthy subjects in Iran from 1992 to 2013. Iran J Basic Med Sci. 2015;18(7):627\u201334.","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"11110_CR22","first-page":"337","volume":"42","author":"B Mutlu","year":"2008","unstructured":"Mutlu B, et al. Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients? Mikrobiyol Bul. 2008;42(2):337\u201341.","journal-title":"Mikrobiyol Bul"},{"issue":"4","key":"11110_CR23","first-page":"360","volume":"35","author":"M Erfanianahmadpoor","year":"2014","unstructured":"Erfanianahmadpoor M, et al. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study. Saudi Med J. 2014;35(4):360\u20134.","journal-title":"Saudi Med J"},{"issue":"4","key":"11110_CR24","first-page":"451","volume":"31","author":"Y Uyar","year":"2008","unstructured":"Uyar Y, et al. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol. 2008;31(4):451\u20135.","journal-title":"New Microbiol"},{"issue":"5\u20136","key":"11110_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000506051","volume":"62","author":"MK Almaghrabi","year":"2019","unstructured":"Almaghrabi MK, et al. Seroprevalence of Human Cytomegalovirus in Pregnant Women in the Asir Region Kingdom of Saudi Arabia. Intervirology. 2019;62(5\u20136):205\u20139. https:\/\/doi.org\/10.1159\/000506051.","journal-title":"Intervirology"},{"issue":"1","key":"11110_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000354758","volume":"23","author":"N Kamel","year":"2014","unstructured":"Kamel N, et al. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing. Med Princ Pract. 2014;23(1):29\u201333. https:\/\/doi.org\/10.1159\/000354758.","journal-title":"Med Princ Pract"},{"issue":"2","key":"11110_CR27","doi-asserted-by":"publisher","first-page":"e21860","DOI":"10.7759\/cureus.21860","volume":"14","author":"W Mahallawi","year":"2022","unstructured":"Mahallawi W, et al. Human Cytomegalovirus Seroprevalence Among Blood Donors in the Madinah Region, Saudi Arabia. Cureus. 2022;14(2):e21860. https:\/\/doi.org\/10.7759\/cureus.21860.","journal-title":"Cureus"},{"issue":"4","key":"11110_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jiph.2013.08.006","volume":"7","author":"ZK Aljumaili","year":"2014","unstructured":"Aljumaili ZK, Alsamarai AM, Najem WS. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk. Iraq J Infect Public Health. 2014;7(4):277\u201388. https:\/\/doi.org\/10.1016\/j.jiph.2013.08.006.","journal-title":"Iraq J Infect Public Health"},{"issue":"3","key":"11110_CR29","first-page":"235","volume":"23","author":"N Abuharfeil","year":"2000","unstructured":"Abuharfeil N, Meqdam MM. Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan. New Microbiol. 2000;23(3):235\u20139.","journal-title":"New Microbiol"},{"issue":"5","key":"11110_CR30","doi-asserted-by":"publisher","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, et al. Seroprevalence of Epstein-Barr virus infection in U.S. Children ages 6\u201319, 2003\u20132010. PLoS One. 2013;8(5):e64921. https:\/\/doi.org\/10.1371\/journal.pone.0064921.","journal-title":"PLoS One"},{"issue":"1","key":"11110_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","volume":"20","author":"A Kuri","year":"2020","unstructured":"Kuri A, et al. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health. 2020;20(1):912. https:\/\/doi.org\/10.1186\/s12889-020-09049-x.","journal-title":"BMC Public Health"},{"issue":"1","key":"11110_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115836","volume":"10","author":"CY Chen","year":"2015","unstructured":"Chen CY, et al. A large-scale seroprevalence of Epstein-Barr virus in Taiwan. PLoS ONE. 2015;10(1): e0115836. https:\/\/doi.org\/10.1371\/journal.pone.0115836.","journal-title":"PLoS ONE"},{"issue":"12","key":"11110_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.26719\/2017.23.12.821","volume":"23","author":"E Farid","year":"2018","unstructured":"Farid E, Al-Biltagi M. Trend and seroprevalence of Epstein-Barr virus in Bahrain: 2001\u20132015. East Mediterr Health J. 2018;23(12):821\u20139. https:\/\/doi.org\/10.26719\/2017.23.12.821.","journal-title":"East Mediterr Health J"},{"issue":"12","key":"11110_CR34","doi-asserted-by":"publisher","first-page":"e0189033","DOI":"10.1371\/journal.pone.0189033","volume":"12","author":"MK Smatti","year":"2017","unstructured":"Smatti MK, et al. Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar. PLoS ONE. 2017;12(12):e0189033. https:\/\/doi.org\/10.1371\/journal.pone.0189033.","journal-title":"PLoS ONE"},{"key":"11110_CR35","doi-asserted-by":"publisher","first-page":"100641","DOI":"10.1016\/j.nmni.2019.100641","volume":"34","author":"S Sharifipour","year":"2020","unstructured":"Sharifipour S, Davoodi Rad K. Seroprevalence of Epstein-Barr virus among children and adults in Tehran Iran. New Microbes New Infect. 2020;34:100641. https:\/\/doi.org\/10.1016\/j.nmni.2019.100641.","journal-title":"New Microbes New Infect"},{"issue":"1","key":"11110_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12883-020-01977-w","volume":"20","author":"RM Kofahi","year":"2020","unstructured":"Kofahi RM, et al. Prevalence of seropositivity of selected herpesviruses in patients with multiple sclerosis in the North of Jordan. BMC Neurol. 2020;20(1):397. https:\/\/doi.org\/10.1186\/s12883-020-01977-w.","journal-title":"BMC Neurol"},{"key":"11110_CR37","unstructured":"Jordanian Department of Statistics. Jordan in Figures 2020 2020; Available from: http:\/\/dosweb.dos.gov.jo\/DataBank\/JordanInFigures\/Jorinfo_2020.pdf."},{"issue":"1","key":"11110_CR38","first-page":"14","volume":"6","author":"MA Pourhoseingholi","year":"2013","unstructured":"Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14\u20137.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"11110_CR39","first-page":"9","volume":"1","author":"L Naing","year":"2006","unstructured":"Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9\u201314.","journal-title":"Arch Orofac Sci"},{"issue":"11","key":"11110_CR40","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/23744235.2024.2365906","volume":"56","author":"O Supplisson","year":"2024","unstructured":"Supplisson O, et al. Seroprevalence of human herpes viruses in France, 2018\u20132022: a multilevel regression and poststratification approach. Infect Dis (Lond). 2024;56(11):931\u201345. https:\/\/doi.org\/10.1080\/23744235.2024.2365906.","journal-title":"Infect Dis (Lond)"},{"issue":"6","key":"11110_CR41","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10096-020-03814-x","volume":"39","author":"S Hoehl","year":"2020","unstructured":"Hoehl S, et al. Thirty years of CMV seroprevalence-a longitudinal analysis in a German university hospital. Eur J Clin Microbiol Infect Dis. 2020;39(6):1095\u2013102. https:\/\/doi.org\/10.1007\/s10096-020-03814-x.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"11110_CR42","first-page":"348","volume":"20","author":"A Kothari","year":"2002","unstructured":"Kothari A, et al. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi. India J Health Popul Nutr. 2002;20(4):348\u201351.","journal-title":"India J Health Popul Nutr"},{"issue":"1","key":"11110_CR43","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1186\/s12889-016-3772-8","volume":"16","author":"S Ibrahim","year":"2016","unstructured":"Ibrahim S, et al. Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey. BMC Public Health. 2016;16(1):1112. https:\/\/doi.org\/10.1186\/s12889-016-3772-8.","journal-title":"BMC Public Health"},{"issue":"8\u20139","key":"11110_CR44","first-page":"512","volume":"78","author":"J Gargouri","year":"2000","unstructured":"Gargouri J, et al. Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med. 2000;78(8\u20139):512\u20137.","journal-title":"Tunis Med"},{"issue":"12 Suppl","key":"11110_CR45","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.4314\/eamj.v86i12.62903","volume":"86","author":"DG Njeru","year":"2009","unstructured":"Njeru DG, et al. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre. Nairobi East Afr Med J. 2009;86(12 Suppl):S58-61. https:\/\/doi.org\/10.4314\/eamj.v86i12.62903.","journal-title":"Nairobi East Afr Med J"},{"issue":"2","key":"11110_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/095646249000100206","volume":"1","author":"SO Ismail","year":"1990","unstructured":"Ismail SO, et al. Sexually transmitted diseases in men in Mogadishu Somalia. Int J STD AIDS. 1990;1(2):102\u20136. https:\/\/doi.org\/10.1177\/095646249000100206.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"11110_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/s0037-86822010000400004","volume":"43","author":"MA Souza","year":"2010","unstructured":"Souza MA, et al. Seroprevalence of cytomegalovirus antibodies in blood donors in southern Brazil. Rev Soc Bras Med Trop. 2010;43(4):359\u201361. https:\/\/doi.org\/10.1590\/s0037-86822010000400004.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"11110_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/CVI.00697-14","volume":"22","author":"TM Lanzieri","year":"2015","unstructured":"Lanzieri TM, et al. Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012. Clin Vaccine Immunol. 2015;22(2):245\u20137. https:\/\/doi.org\/10.1128\/CVI.00697-14.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"11110_CR49","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, et al. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6\u201319 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208(8):1286\u201393. https:\/\/doi.org\/10.1093\/infdis\/jit321.","journal-title":"J Infect Dis"},{"issue":"5","key":"11110_CR50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/OLQ.0b013e3181644b70","volume":"35","author":"SA Staras","year":"2008","unstructured":"Staras SA, et al. Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988\u20131994. Sex Transm Dis. 2008;35(5):472\u20139. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181644b70.","journal-title":"Sex Transm Dis"},{"issue":"10","key":"11110_CR51","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1086\/656918","volume":"51","author":"LP Stadler","year":"2010","unstructured":"Stadler LP, et al. Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males. Clin Infect Dis. 2010;51(10):e76-81. https:\/\/doi.org\/10.1086\/656918.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11110_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29525","volume":"96","author":"W Dana Flanders","year":"2024","unstructured":"Dana Flanders W, et al. Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada. J Med Virol. 2024;96(3): e29525. https:\/\/doi.org\/10.1002\/jmv.29525.","journal-title":"J Med Virol"}],"updated-by":[{"DOI":"10.1186\/s12879-025-11245-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11110-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11110-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11110-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T06:40:01Z","timestamp":1751265601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11110-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11110"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11110-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-025-11245-2","URL":"https:\/\/doi.org\/10.1186\/s12879-025-11245-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board (IRB) of Jordan University of Science and Technology (Ref: 8\/140\/2021, date 28.04.2021) and the ethics committee of the Jordanian Ministry of Health (Ref: Moh\/REC\/2021\/131, date 26.07.2021) before the recruitment of study participants. Written informed consent was obtained from each adult participant. A parent or legal guardian for child participants was required to complete a written informed consent form before participation. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication:"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"724"}}